Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Extending Omalizumab Treatment Intervals in Patients with Chronic Spontaneous Urticaria
Phase 4
Recruiting
- Conditions
- Chronic Spontaneous UrticariaChronic Urticaria, Idiopathic
- Interventions
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Simon Francis Thomsen
- Target Recruit Count
- 40
- Registration Number
- NCT05916937
- Locations
- 🇩🇰
Department of Dermatology, Bispebjerg Hospital, Copenhagen, Copenhagen N, Denmark
News
No news found